• 2009.03.01 Visgeneer acquired an approval from Chunghwa Post Co., Ltd. to sell Coresence skin care series at their distribution channels.
• 2008.12.01 Received R.O.C patent NO. M346004; Title: A traveling biosensor with voice output and rechargeable function.
• 2008.08.08 Visgeneer purchases a factory and office building in responding to the requirement of increasing production lines.
• 2008.07.30 Visgeneer acquired an approval of adding new production items (CODE 09700612140) on the previous "Newly Emerging, Important, and Strategic Industries" (CODE 09600967610) certified by the Industrial Department Bureau, Ministry of Economic Affairs.
• 2008.07.28 We attended AACC Exhibition in Washington D.C, USA (7.28～08.01) and demonstrated Blood Glucose Monitoring System and 3 in 1 Remote Health Monitoring System.
• 2008.06.09 Taiwan Fertilizer, a listed company (1722), acquired a director and a supervisor of the board in the shareholder meeting of Visgeneer inc. in 2008.
• 2008.06.06 Economic Daily News: Revenue has increased in 2008.
• 2008.02.22 Visgeneer acquired blood glucose monitor approval from the State Food and Drug Administration of the PRC.
• 2008.01.23 Received an approval of “Emerging, Important, and Strategic Industries” from the Industrial Department Bureau, Ministry of Economic Affairs.(NO 09600967610)
• 2007.11.26 Meeting of stockholders elected Taiwan Fertilizer Co., Ltd. as a Member of Board,Visgeneer Inc.
• 2007.11.14~17 Visgeneer Inc. participated in Dusseldorf, Germany's Medica 2007 Medical Devices Exhibition.
• 2007.05.17 Visgeneer has received a certification of "Emerging, Important, and Strategic Industries" from the Industrial Department Bureau, Ministry of Economic Affairs.
• 2007.03.02 Visgeneer eBsensor blood glucose factory is approved with Good Manufacturing Practice of Medical Device. (GMP Certification No. 0960302217)
• 2007.02.27 Institutional Review Board of Hsin Chu General Hospital, Department of Health has passed a resolution on 8/Feb/07 and signed a research collaboration contract with Visgeneer Inc. on 27/Feb/2007.
• 2007.01.15 Visgeneer has received CE Mark (CE0123) for the eBsensor Blood Glucose Monitoring System.
  certification from TUV PS.
• 2007.01.15 Visgeneer medical device factory has received ISO13485 : 2003.
• 2006.12.28 eBsensor Blood Glucose Monitoring System received US FDA 510K approval (No. K062555).
• 2006.12.22 Received P.R.O.C patent NO 876373; Title: Structures of biosensor strips.
• 2006.12.15 Visgeneer Cosmetic factory has received ISO9001:2000 certification from TUV PS.
• 2006.12.11 Received ‘Small Business Innovation Research (SBIR) Subsidy Plan 2006’ entitled “A study of pathogenesis of T-cell lymphoblastic lymphoma” from the Industrial Department Bureau, Ministry of Economic Affairs.
• 2006.11.27 eBsensor Blood Glucose is approved with EN61010-1(2001) Standard.
• 2006.11.25 eBsensor Blood Glucose is approved with EN61326-1 Standard.
• 2006.10.23 Received an approval of “Emerging, Important, and Strategic Industries” from the Industrial Department Bureau, Ministry of Economic Affairs. (NO 09500828690)
• 2006.9.21 The clinical study of eBsensor entitled "Clinical evaluation of the eBsensor hand-held blood glucose monitoring system" was accepted for publication in Clin Chim Acta
• 2006.9.11 Received R.O.C patent NO. M297470; Title: Structures of biosensor strips.
• 2006.8.15 eBsensor Blood Glucose is approved with EN60601-1(1990) +A1(1993) +A2(1995) +A13(1996) Standard.
• 2006.8.14 eBsensor Blood Glucose is approved with EN60601-1-2 : 2000 Standard.

• Bonus : Year-End Bonus; Employee Stock Bonus
• Insurance : Labor Insurance , National Health Insurance , Group Insurance for Accident
• Leave: Annual Leave, 2 Days Off
• Physical Examination